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ARTICLE
The Rad51 paralogs facilitate a novel DNA strand
speciﬁc damage tolerance pathway
Joel C. Rosenbaum 1,11, Braulio Bonilla2,11, Sarah R. Hengel2,11, Tony M. Mertz3, Benjamin W. Herken2,
Hinke G. Kazemier4, Catherine A. Pressimone2, Timothy C. Ratterman 5, Ellen MacNary3, Alessio De Magis6,
Youngho Kwon7,8, Stephen K. Godin2, Bennett Van Houten 9, Daniel P. Normolle10, Patrick Sung7,8,
Subha R. Das 5, Katrin Paeschke 4,6, Steven A. Roberts3, Andrew P. VanDemark 1 & Kara A. Bernstein 2
Accurate DNA replication is essential for genomic stability and cancer prevention. Homo-
logous recombination is important for high-ﬁdelity DNA damage tolerance during replication.
How the homologous recombination machinery is recruited to replication intermediates is
unknown. Here, we provide evidence that a Rad51 paralog-containing complex, the budding
yeast Shu complex, directly recognizes and enables tolerance of predominantly lagging strand
abasic sites. We show that the Shu complex becomes chromatin associated when cells
accumulate abasic sites during S phase. We also demonstrate that puriﬁed recombinant Shu
complex recognizes an abasic analog on a double-ﬂap substrate, which prevents AP endo-
nuclease activity and endonuclease-induced double-strand break formation. Shu complex
DNA binding mutants are sensitive to methyl methanesulfonate, are not chromatin enriched,
and exhibit increased mutation rates. We propose a role for the Shu complex in recognizing
abasic sites at replication intermediates, where it recruits the homologous recombination
machinery to mediate strand speciﬁc damage tolerance.
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DNA is constantly damaged by endogenous and exogenoussources such as alkylating agents, reactive oxygen species,and radiation. Each type of DNA damage is recognized
and repaired using a specialized repair pathway. Repair of DNA
base damage by base excision repair (BER) begins with recogni-
tion and excision of the damaged base by a DNA glycosylase
resulting in abasic [also known as apurinic/apyrimidinic (AP)]
site formation. In mammalian cells, spontaneous depurination
events and repair of endogenous DNA damage generates between
10,000 and 30,000 abasic sites per day1–3, making them one of the
most common genotoxic lesions. Most abasic sites are repaired in
an high-ﬁdelity manner by the subsequent steps of BER. During
replication, abasic sites are strong blocks to the replication DNA
polymerases epsilon and delta4,5. When synthesis at a replication
fork is blocked by an abasic site, the lesion must be bypassed.
Abasic sites within the context of DNA replication are often
resolved by either low-ﬁdelity translesion DNA synthesis (TLS)5
or high-ﬁdelity homologous recombination (HR)6. How abasic
sites at stalled replication forks are targeted to distinct bypass/
repair pathways remains largely unknown.
The Rad51 paralogs are a highly conserved family of proteins
structurally similar to the central HR protein, Rad51 (ref. 7). The
Rad51 paralogs form sub-complexes that aid in Rad51 ﬁlament
formation and strand invasion, two key steps in HR. Mutations in
the human RAD51 paralogs are associated with predisposition to
breast and ovarian cancer as well as Fanconi anemia-like
syndromes8,9. The Shu complex is an evolutionarily conserved
complex, which contains Rad51 paralogs. The Saccharomyces
cerevisiae Shu complex is a heterotetramer composed of Shu2 (a
SWIM-domain-containing protein) and the Rad51 paralogs
Csm2, Psy3, and Shu1 (refs. 10–13). Shu complex mutant cells are
especially sensitive to the alkylating agent, methyl methane-
sulfonate (MMS), which among other agents causes replication
blocking lesions, suggesting that the Shu complex may help
facilitate their repair10,14–17.
Here we provide evidence that DNA-binding components of
the budding yeast Shu complex, Csm2-Psy3, bind double-ﬂap
DNA substrates containing an abasic site analog, and increase
chromatin association when abasic sites accumulate. Importantly,
Csm2-Psy3 blocks AP endonuclease cleavage at a double-ﬂap
DNA substrate, thus preventing in vitro DSB formation. Fur-
thermore, we show that Csm2-Psy3 also aids in preventing TLS-
induced mutations that arise in the lagging strand during repli-
cation of DNA templates containing abasic sites. Therefore, we
propose a model whereby the Shu complex directly recognizes
abasic sites on the lagging strand of a replication fork to facilitate
a error-free, strand-speciﬁc damage tolerance pathway.
Results
Csm2 is the primary DNA-binding subunit. To determine the
role of DNA binding in S. cerevisiae Shu complex function, we
modeled the putative DNA-binding loops of the Shu complex
members, the Rad51 paralogs, Csm2 and Psy3 (ref. 18). We
mutated the lysine and arginine residues within these predicted
DNA-binding loops (for Csm2: K189A, R190A, R191A, R192A;
csm2-KRRR) (for Psy3: K199A, R200A, K201A; psy3-KRK)12
(Fig. 1a). To assess the DNA-binding capabilities of Csm2-KRRR
and Psy3-KRK, we co-expressed and puriﬁed Csm2-Psy3, Csm2-
Psy3-KRK, Csm2-KRRR-Psy3, and Csm2-KRRR-Psy3-KRK
complexes from Escherichia coli and assessed their capacity to
bind their preferred DNA substrate, double-ﬂap DNA substrate
or Y DNA19, by ﬂuorescence polarization anisotropy (Fig. 1b,
Supplementary Fig. 1, Supplementary Table 1). Whereas Csm2-
Psy3 binds the double-ﬂap DNA substrate with an equilibrium
dissociation constant (Kd) of 435 ± 37 nM, Csm2-KRRR-Psy3,
and Csm2-KRRR-Psy3-KRK mutant proteins exhibit minimal
DNA binding, while Csm2-Psy3-KRK exhibits more than a six-
fold reduction in DNA-binding afﬁnity relative to Csm2-Psy3
(Kd > 2.8 µM; Fig. 1b, Supplementary Table 1). These results
indicate that Csm2 is the primary DNA-binding subunit.
Csm2-Psy3 DNA binding is necessary for repair in vivo. We
next asked whether the Csm2-Psy3 DNA-binding activity would
be important for their function in vivo. To address this question,
we analyzed S. cerevisiae cells expressing csm2-KRRR and psy3-
KRK DNA-binding mutants for MMS sensitivity. We observe
very modest MMS sensitivity of csm2-KRRR cells, while psy3-KRK
cells are largely insensitive to 0.02% MMS, and the csm2-KRRR
psy3-KRK double-mutant cells exhibit increased MMS sensitivity
and reduced viability compared to the single mutants (Fig. 1c,
Supplementary Fig. 2). We next examined whether Csm2 and
Psy3 DNA binding would be important for suppressing muta-
tions by measuring CAN1 mutation rates (Fig. 1d). Similar to the
MMS sensitivity, we ﬁnd that csm2-KRRR psy3-KRK double
mutant cells exhibit increased spontaneous or MMS-induced
mutation rates compared to wild-type cells (Fig. 1d). We next
used western blot analysis to ensure that the phenotypes we
observed in csm2-KRRR and/or psy3-KRK cells are not due to
altered protein expression (Supplementary Fig. 3a). Similarly, we
do not observe changes in Shu complex integrity or known
protein interactions by yeast-2-hybrid or during recombinant
protein puriﬁcation, where the Csm2-KRRR Psy3-KRK elution
proﬁle is similar to wild-type complexes (Supplementary
Fig. 3b–d). Therefore, Csm2 and Psy3 DNA binding residues are
important for Shu complex function without affecting complex
formation. Furthermore, our ﬁndings suggest that the combined
DNA-binding activities of Csm2 and Psy3 are critical for MMS
resistance and suppressing mutations.
Csm2 is chromatin enriched when abasic sites accumulate. We
ﬁnd that disruption of the DNA-binding activities of Csm2 and
Psy3 leads to increased mutation rates (Fig. 1d) and our previous
work shows that when abasic sites accumulate in csm2Δ cells,
mutation rates increase over 1000-fold14. Therefore, we wanted to
determine if Csm2-Psy3 DNA binding is critical for MMS
resistance in vivo when abasic sites accumulate. Abasic sites can
be forced to accumulate by deleting the enzymes responsible for
their processing, which include the AP endonucleases (APN1
APN2) and AP lyases (NTG1 NTG2). Suggesting that Csm2-Psy3
DNA-binding activities are important when abasic sites accu-
mulate, we observe that csm2-KRRR psy3-KRK apn1Δ apn2Δ
ntg1Δ ntg2Δ cells exhibit increased MMS sensitivity that is
comparable to a csm2Δ apn1Δ apn2Δ ntg1Δ ntg2Δ cell (Fig. 2a).
Since we ﬁnd that the Shu complex binds most tightly to
double-ﬂap DNA12,19 and is important for resistance to abasic
sites (Fig. 2a), we hypothesized that Csm2-Psy3 may be enriched
at chromatin when abasic sites accumulate during replication. To
test this hypothesis, we performed chromatin fractionation
experiments. We ﬁrst arrested Csm2-6HA-expressing cells (with
or without apn1Δ apn2Δ ntg1Δ ntg2Δ) in G1 with alpha factor
and released these cells into 0.02% MMS for 1 h before lysis and
fractionation. We observe that Csm2 chromatin association
increases 4.5-fold when abasic sites accumulate and this
enrichment depends on Csm2 DNA-binding activity (Fig. 2b).
In contrast to Csm2, we ﬁnd that RPA chromatin association
occurs independently of Csm2 DNA-binding activity (Supple-
mentary Fig. 4a).
We next examined whether Csm2 chromatin association
increases in an MMS dose-dependent manner. To test this, we
treated Csm2-6HA-expressing cells (with or without apn1Δ
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apn2Δ ntg1Δ ntg2Δ) with different MMS concentrations for 1 h
(0%, 0.01%, 0.02%, and 0.03%). Importantly, we observe Csm2
chromatin association increases in an MMS dose-dependent
manner (~2- to 7-fold) when abasic sites accumulate (Fig. 2c; p=
0.02 for 0.02% MMS and p= 0.01 for 0.03% MMS). We also
observe a reproducible, although not statistically signiﬁcant, two-
fold increase in Csm2 chromatin association in WT cells
comparing untreated to 0.03% MMS (Fig. 2c). Consistent with
speciﬁcity for MMS-induced damage and abasic sites, we do not
observe Csm2 enrichment when forks are stalled with HU
(Supplementary Fig. 4b). Overall, these results suggest that the
Shu complex is enriched at chromatin when abasic sites
accumulate.
Csm2-Psy3 suppress lagging strand abasic site mutations. To
determine if Csm2 and Psy3 facilitate the bypass of abasic sites,
we assessed how disruption of these genes inﬂuence the CAN1
mutation rate and spectrum induced by the human cytidine
deaminase, APOBEC3B. APOBEC family cytidine deaminases
induce genomic hypermutation in human tumors20–22. Bioin-
formatic analysis of mutations in cancer genomes23–25 and
experiments in yeast26 and bacterial systems27 indicate that
APOBECs deaminate the lagging strand template during DNA
replication. APOBEC3B-induced mutation rates and spectra were
previously measured within yeast with CAN1 at a location 16 kB
centromere proximal to ARS216. In this setting, APOBEC-
induced mutations occur primarily at G bases in leftward moving
forks due to deamination of cytidines on the lagging DNA
strand26,28 (Fig. 3a). Moreover, the APOBEC3B-induced dU is
efﬁciently removed by the uracil glycosylase, Ung1, which results
in formation of synthesis-blocking abasic sites on the template of
Okazaki fragments (Fig. 3a). We used this system to determine if
Csm2 and Psy3 facilitate bypass of abasic sites induced by
APOBEC3B during replication of the lagging strand in vivo. We
ﬁnd that combining APOBEC3B expression with Shu complex
defects results in a synergistic increase in CAN1 mutation rates to
levels observed in ung1 deletion strains, in which all APOBEC3B-
induced lesions are converted to mutations (Fig. 3b). Importantly,
CSM2 or PSY3 deletion in combination with ung1Δ results in
mutation rates similar to the ung1 single deletion (Fig. 3b),
indicating that Shu complex genes are epistatic with UNG1 in
their ability to decrease APOBEC3B-induced mutation. Sequen-
cing of can1 mutants from csm2Δ ung1Δ produced nearly
exclusively G to A transitions (Fig. 3c), conﬁrming that Ung1
operates prior to Csm2 in avoiding APOBEC3B-induced muta-
tions. In contrast, CAN1 mutation spectra in both csm2Δ and
psy3Δ cells revealed both G to C transversions and G to A
transitions, consistent with mutations caused by Rev1-mediated
and A-rule polymerase-mediated TLS past abasic sites28
Fig. 1 Csm2-Psy3 DNA binding is important for Shu complex function.
a Surface view of S. cerevisiae Csm2 (light gray; K189, R190, R191, R192) and
Psy3 (dark gray; K199, R200, K201) with the predicted DNA-binding
residues highlighted in magenta and predicted DNA-binding loops in light
and dark blue, respectively (ref. 12; model structure derived from PDB
3VU9). b In vitro analysis of Csm2-Psy3 binding to a DNA fork substrate
compared to Csm2-Psy3 DNA-binding mutants (Csm2-K189A/R190A/
R191A/R192A and/or Psy3-K199A/R200A/K201A) by ﬂuorescence
anisotropy. Increasing concentrations of Csm2-Psy3 or the indicated
mutants were added to 25 nM 3′-ﬂuorescein-labeled double-ﬂap substrate
and DNA binding was assessed. Dissociation constants (Kd) and associated
standard deviations from triplicate experiments were determined by non-
linear curve ﬁtting to a one-site binding model. c Cells expressing the csm2-
KRRR psy3-KRK double mutant exhibit increased MMS sensitivity relative to
csm2-KRRR or psy3-KRK cells. The DNA-binding residues shown in a were
mutated to alanines and integrated into the genomic CSM2 and PSY3 loci.
Fivefold serial dilution of WT, csm2Δ, psy3Δ, csm2-KRRR, psy3-KRK, and
csm2-KRRR psy3-KRK cells onto rich YPD medium or YPD medium
containing 0.02% MMS were incubated for 2 days at 30 °C prior to being
photographed. d Spontaneous and MMS-induced mutation rate at the CAN1
locus were measured in WT, csm2Δ, psy3Δ, csm2-KRRR, psy3-KRK, and
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generated by Ung1 glycosylase activity. Moreover, the can1
mutations in the csm2Δ and psy3Δ strains maintained a G
nucleotide strand-bias observed in wild type and exacerbated in
ung1Δ cells (Fig. 3d), which is indicative of lagging strand-
associated mutagenesis. Together these results indicate that the
Shu complex promotes an error-free template switch mechanism
to inhibit the conversion of abasic sites in the lagging strand
template to mutations.
Csm2-Psy3 binds to abasic site analogs in double-ﬂap DNA.
Since we observe that the Shu complex is important for error-free
bypass of abasic sites during replication, we asked if Csm2-Psy3
could directly recognize abasic sites in a double-ﬂap DNA sub-
strate. To address this question, we created oligonucleotides
containing the abasic (tetrahydrofuran, THF) site analog29 along
the 3′ (AP1–4) or 5′ (AP5–8) strand of a double-ﬂap substrate
(Fig. 4a). Although the Csm2-Psy3 heterodimer binds all of the
DNA substrates as revealed by equilibrium-binding assays using a
ﬂuorescence polarization anisotropy technique, we observe an
almost two-fold improved afﬁnity (lower Kd) to a double-ﬂap
substrate containing an abasic site analog on the ssDNA at the
ssDNA/dsDNA junction on the 5′ strand [AP6; Kd= 71 ±
7.3 nM; Fig. 4b, c, Supplementary Table 2]. To determine if
Csm2-Psy3 binding to AP6 is sequence dependent, we changed
the nucleotide opposite of the abasic site analog and examined
DNA binding by electrophoretic mobility shift assay (EMSA;
Supplementary Fig. 5a). The preferential binding of Csm2-Psy3 to
AP6, and the adjacent AP7, occurs independently of the
nucleotide sequence (Supplementary Fig. 5a). It is interesting that
we do not observe increased Csm2-Psy3 DNA binding with AP7
by anisotropy or EMSA. Furthermore, the different binding
afﬁnities between Csm2-Psy3 with AP6 and AP7 are not distin-
guishable by EMSA analysis, which is a qualitative and less sen-
sitive assay. Note that the condition where we are able to visualize
Csm2-Psy3 protein-DNA complexes in the acrylamide gel, and
not in the wells, is in the presence of 5% glycerol. The addition of
glycerol may stabilize and inhibit the dissociation of substrate
from Csm2-Psy3-DNA complexes in the gel matrix in compar-
ison to the quantitative equilibrium afﬁnities obtained above.
Next, we determined whether Csm2-Psy3 would bind with
improved afﬁnity to a DNA structure that more closely resembles
an in vivo replication fork with one or two dsDNA regions30.
Using an EMSA, we ﬁnd that Csm2-Psy3 binds to double-ﬂap, 5′
Fig. 2 Csm2 is recruited to chromatin when abasic sites accumulate.
a Csm2-Psy3 DNA binding is critical for survival when abasic sites
accumulate. Fivefold serial dilutions of the indicated yeast strains on rich
medium (YPD) or rich medium containing 0.002% MMS. Abasic sites
accumulate by combined disruption of the AP endonucleases (APN1, APN2)
and AP lyases (NTG1, NTG2) in the presence of MMS. Csm2-Psy3 double
DNA-binding mutant (csm2-KRRR psy3-KRK) exhibits similar MMS
sensitivity to csm2Δ cells when abasic sites accumulate. b Csm2 is enriched
at the chromatin when abasic sites accumulate in a DNA-binding-
dependent manner. Csm2-6HA-expressing cells were synchronized in G1
with alpha factor and released into YPD medium or YPD medium
containing 0.02% MMS for 1 h before cellular fractionation. Csm2 protein
levels from whole-cell extract (W), supernatant (S), and chromatin (C)
fractions from the indicated strains were determined by western blot using
HA antibody. Kar2 and histone H2B were used as fractionation controls (S
and C, respectively). The results from three to ﬁve experiments were
plotted with standard deviations, as fold enrichment relative to the
untreated WT (Csm2-6HA). The p value between Csm2-6HA apn1Δ apn2Δ
ntg1Δ ntg2Δ and WT (treated and untreated) or csm2-KRRR-6HA apn1Δ
apn2Δ ntg1Δ ntg2Δ was calculated using an unpaired two-tailed Student’s t-
test between experimental samples and in each case was p≤ 0.05. c Csm2
chromatin association increases in an MMS dose-dependent manner. Same
as b except that Csm2-6HA or Csm2-6HA apn1Δ apn2Δ ntg1Δ ntg2Δ were
treated with 0%, 0.01%, 0.02%, or 0.03% MMS and results were
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ﬂap, and 3′ ﬂap substrates with similar afﬁnities and to a static
replication fork with decreased afﬁnity (Supplementary Fig. 5b).
These results are consistent with decreased Csm2-Psy3 binding
afﬁnity for dsDNA19. Furthermore, we ﬁnd that the full Shu
complex (Csm2-Psy3-Shu1-Shu2) recapitulates observed
substrate-binding afﬁnities for AP6 (Kd= 72 ± 17 nM) and WT
(Kd= 174 ± 22 nM) double-ﬂap DNA compared to Csm2-Psy3
alone (Fig. 4d). Consistent with a lack of Shu1-Shu2 DNA-
binding activity11, we ﬁnd that Shu1-Shu2 do not bind to AP6
(Supplementary Fig. 6a). Similarly, we do not observe a
qualitative change in DNA binding between Csm2-Psy3 and the
full Shu complex by EMSA (Supplementary Fig. 6b). Together,
these results demonstrate that Csm2-Psy3-Shu1-Shu2 bind
double-ﬂap DNA substrates containing an abasic site analog
in vitro.
Csm2-Psy3 protects abasic site analogs from APE1 cleavage.
AP endonucleases cleave DNA adjacent to an abasic site to
generate a 5′ deoxyribophosphate (5′dRP). Human APE1 is
capable of incising abasic sites in both double-stranded and to a
lesser extent single-stranded DNA31. In the context of DNA
replication, abasic site cleavage would result in fork collapse and
DSB formation. Since we ﬁnd that Csm2-Psy3 binds to double-
ﬂap DNA structure containing an abasic site analog THF at the
ﬂap junction (AP6; Fig. 4a, c), we hypothesized that Csm2-Psy3
binding would inhibit AP endonuclease activity towards AP6. To
test this hypothesis, we performed endonuclease assays using
human APE1 with the AP6 substrate in the presence or absence
of Csm2-Psy3. Indeed, we observe reduction of AP endonuclease
cleavage of AP6 upon increasing concentration of Csm2-Psy3
protein (Fig. 5a). Using in vitro pull-down experiments, we ﬁnd
that Csm2-Psy3 inhibition of APE1 activity towards AP6 is
unlikely due to a direct interaction between these proteins
(Supplementary Fig. 7). The endonuclease assay was initially
incubated for one minute to limit the number of APE1 catalytic
cycles. However, we observe signiﬁcantly reduced AP6 cleavage in
the presence of Csm2-Psy3 even over an extended time course
(Fig. 5b). APE1 cleavage is most effective on double-ﬂap sub-
strates where the abasic site analog is in the dsDNA region (AP8),
consistent with previous ﬁndings (32; Supplementary Fig. 8a, b,
compare AP6 to AP8). Therefore, Csm2-Psy3 attenuates AP
endonuclease cleavage and DSB formation by binding to an
abasic site at the double-ﬂap junction.
We next determined whether the presence of Rad51 or Shu1-
Shu2 would alter Csm2-Psy3 inhibition of AP6 cleavage by APE1.
To do this, we determined that Rad51 binds to AP6, but with
decreased afﬁnity than Csm2-Psy3 and is saturated at 2 µM
(Supplementary Fig. 9). We next tested whether Rad51 would
block AP6 cleavage by APE1 and ﬁnd that it does (Fig. 5c). We
then examined whether Csm2-Psy3 together with Rad51 (2 µM)
would further inhibit APE1 endonuclease activity. We ﬁnd that
the presence of both Rad51 and Csm2-Psy3 reduces APE1
endonuclease activity the most (Supplementary Fig. 8c). In
contrast, Shu1-Shu2 does not signiﬁcantly increase Csm2-Psy3
inhibition of APE1 cleavage in the presence of Rad51 (Fig. 5d).
Fig. 3 The Shu complex promotes bypass of APOBEC3B-induced lesions.
a APOBEC3B-induced mutation rates on the lagging strand of a replication
fork measured using a CAN1 reporter integrated 16 kb from ARS216 on
chromosome II. Expression of the cytidine deaminase APOBEC3B induces
primarily lagging strand mutations caused by dU templated replication (G
to A transition). The uracil glycosylase Ung1 removes U resulting in abasic
site formation (AP) in the lagging strand, which can be bypassed by TLS (G
to A transition, G to C transversion). b CSM2 and PSY3 are in the same
pathway as UNG1 and their deletion results in similar mutation rates
individually or in combination with each other. Mutation rates of the
indicated genotypes were measured in CAN1 reporter strains transformed
with either an empty or APOBEC3B-expressing vector. Error bars indicate
95% conﬁdence intervals. c In the absence of CSM2 or PSY3, abasic sites
accumulate and TLS predominates resulting in primarily G to A transitions
(red) or G to C transversions (green) within the CAN1 locus. APOBEC3B
expression in WT, ung1Δ, or csm2Δ ung1Δ cells primarily result in G to A
transitions. The rate reported represents the proportion of the CanR
mutants observed from sequencing multiplied by the mutation rate
determined in b. G to T substitutions are indicated in blue. Other mutations
consisting of rare substitutions at A:T base pairs, insertions, deletions, and
complex events composed of multiple mutations are depicted in purple.
d The strand bias of CAN1 mutations from APOBEC3B expression was
evaluated by Sanger sequencing. APOBEC3B expression results in a
mutation bias in the lagging strand from templated replication of C
deaminations. CSM2, PSY3, or UNG1 deleted cells exhibit more G mutations
(green) than C mutations (red). Other mutations as deﬁned in b are
indicated in purple. Individual mutation rates were calculated as in c.
Statistical signiﬁcance of strand bias in APOBEC3B-expressing strains was
determined by a two-tailed G-test with p < 0.05 for all genotypes
C
TLS induced mutation:
G to A or G to C mutations   
Templated replication:
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Together these results suggest that both Rad51 and Csm2-Psy3-
Shu1-Shu2 are capable of blocking APE1 endonuclease activity.
Discussion
DNA damage can arise from many different sources and damage
that is encountered by the replication fork can result in fork
stalling, collapse, and DSB formation (Fig. 6). Our results suggest
that the leading and lagging strands may be differentially recog-
nized by speciﬁc DNA repair factors and targeted for repair
through unique mechanisms. For example, the lagging strand
contains more ssDNA regions, which inherently make it more
prone to spontaneous damage as well as accessible to DNA-
damaging agents. Here we propose that the Rad51 paralogs,
Csm2-Psy3, directly recognize and tolerate abasic sites (Fig. 6).
Rad51 paralog binding to abasic sites prevents AP endonuclease
cleavage and potential formation of cytotoxic DSBs. This function
is not unprecedented as RPA blocks APE1 cleavage of an abasic
site analog on ssDNA and a double-ﬂap substrate33. It is inter-
esting to note that in mammalian cells, the HMCES protein forms
protein–DNA crosslinks at abasic sites, shielding these sites from
TLS or APE1-induced DSBs34. In contrast, Rad51 paralog bind-
ing to speciﬁc fork blocking lesions, such as an abasic site and
perhaps other fork blocking lesions, would promote Rad51 ﬁla-
ment formation enabling a template switch using the newly
synthesized sister chromatid. By template switching, the lesion
would be bypassed by the replication machinery in an error-free
manner and could subsequently be repaired by BER after the fork
progresses. At the same time, disruption of Shu complex ability to
recognize and bind to abasic sites results in error-prone repair,
such as TLS and single-strand annealing14, to predominate.
Here we present extensive in vitro and in vivo evidence for a
function of the Shu complex in tolerance of abasic sites. We show
that (1) Shu complex member Csm2 chromatin association is
enriched upon abasic site accumulation but not stalled forks
(Fig. 2b, c, Supplementary Fig. 4b); (2) Csm2 DNA binding is
required for its chromatin association when abasic sites accu-
mulate and these mutants exhibit extreme DNA damage sensi-
tivity and are mutagenic (Fig. 2a, b); (3) csm2Δ and psy3Δ
mutants exhibit mutation signatures consistent with abasic site
repair on the lagging strand (Fig. 3); (4) Csm2-Psy3 and Csm2-
Psy3-Shu1-Shu2 bind with improved afﬁnity to a double-ﬂap
substrate containing an abasic site analog (THF) at the junction
(AP6; Fig. 4c, d); and lastly (5) Csm2-Psy3 protects AP6 double-
ﬂap substrates from in vitro endonuclease cleavage (Fig. 5). One
interesting aspect of this study is the twofold improved afﬁnity
observed of Csm2-Psy3 for AP6 but not AP7 (Fig. 4b, c). It is
possible that there is a binding pocket in the Csm2-Psy3 complex
that can accommodate an abasic site analog when it is only in the
Fig. 4 Csm2-Psy3 binds an abasic site analog in double-ﬂap DNA.
a Schematic of double-ﬂap substrates containing abasic site analogs
(tetrahydrofuran; indicated by an arrow and highlighted text) on the 3′
(AP1–4) or 5′ (AP5–8) DNA strand. Note that the complementing
oligonucleotide, which is unmutated, is FITC labeled on the ssDNA end of
the double-ﬂap substrate. b Csm2-Psy3 binds to double-ﬂap substrates
with abasic site analogs along the 3′ DNA with equal afﬁnity. DNA binding
by Csm2-Psy3 was measured by ﬂuorescence anisotropy, with increasing
concentrations of the Csm2-Psy3 heterodimer added to 25 nM ﬂuorescein-
labeled double-ﬂap substrate (AP1–4). Error bars indicate standard
deviations measured in triplicate experiments. Data were ﬁt to a one-site
binding model and average dissociation constants (Kd) were calculated.
Note the improved binding compared to Fig. 1 due to increased sample
purity (described in detail in Supplementary Methods). c Csm2-Psy3 binds
more tightly to a double-ﬂap substrate containing an abasic site analog on
the 5′ oligonucleotide at the junction (AP6, highlighted in red). In vitro-
binding assays as described in b except with double-ﬂap substrates
containing 5′ abasic site analogs (AP5–8). d DNA binding by the Csm2-
Psy3-Shu1-Shu2 was measured by ﬂuorescence anisotropy, with increasing
concentrations of the indicated proteins added to 5 nM AP6 (highlighted in
red) or 2.5 nM double-ﬂap DNA substrate. The data were ﬁt to a quadratic
equation
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WT 122 ± 4.9 nM
AP5 142 ± 11.6 nM
AP6 72 ± 7.3 nM
AP7 112 ± 13.1 nM
AP8 153 ± 16.2 nM 
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AP4 131 ± 17.6 nM


















































Concentration of Csm2-Psy3-Shu1-Shu2 (nM)
WT 174 ± 17 nM
AP6 72 ± 22 nM
Kd
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AP6 position compared to the AP7 position. The nucleotide
adjacent to the abasic site analog may also alter the DNA struc-
ture and therefore inﬂuence DNA binding activity of Csm2-
Psy329,35. In addition, it remains unknown how Rad51 and
Rad55-Rad57, which directly interact with Csm2-Psy3, may
contribute to this substrate speciﬁcity. Future atomic resolution
studies will be necessary to understand the speciﬁcity differences
between these two substrates. Together, the combined in vitro
and in vivo complementary data described above provide the
strongest evidence that the Shu complex has an important role in
tolerance of abasic sites.
Our in vitro ﬁndings suggest a role for the Shu complex in
preventing DSB formation during replication and further studies
are needed to demonstrate that DSBs are indeed increased in vivo
upon Shu complex disruption. However, consistent with
increased DSB formation, Shu complex mutant cells exhibit more
Rad52 foci upon MMS exposure in S/G2/M cells compared to
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Fig. 5 APE1 activity is inhibited by Csm2-Psy3 DNA binding. a Increasing Csm2-Psy3 protein concentrations decrease APE1 activity on a double-ﬂap
substrate containing a lagging strand abasic site analog (AP6). Representative gel and bar graph showing dose-dependent protection of the double-ﬂap
abasic site analog at the junction (AP6, 100 nM) by Csm2-Psy3 (0–5 µM) from APE1 AP endonuclease activity (100 nM). AP6 was incubated with Csm2-
Psy3 or buffer for 5 min before APE1 addition. Reactions were stopped after 1min to limit APE1 catalytic cycles. Error bars indicate standard deviations from
three experiments. b Csm2-Psy3 protects a double-ﬂap substrate containing a 3′ abasic site analog (AP6) over time from AP endonuclease cleavage.
Representative gel and bar graph showing Csm2-Psy3 (5 µM) protection of AP6 (100 nM) from APE1 endonuclease activity (100 nM) over an extended
time course (0–30min). More than 60% of AP6 bound by Csm2-Psy3 persists even after 30min. Error bars represent standard deviations from three
experiments. c Rad51 inhibits APE1 cleavage of AP6 in a concentration-dependent manner. Shown is a representative gel from three experiments. Results
from three experiments are quantiﬁed and error bars represent standard deviations. d Shu1-Shu2 does not signiﬁcantly enhance Csm2-Psy3 protection of
AP6 against APE1 endonuclease. Representative gels and bar graph showing protection of AP6 (100 nM) against APE1 (100 nM) by Shu1-Shu2-Csm2-Psy3
(0–5 µM) with (bottom gel) or without (top gel) added Rad51 (2 µM). Error bars represent standard deviations from three experiments
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MMS exposure in S phase synchronized culture14. It is interesting
to note that csm2Δ in combination with accumulation of abasic
sites (from an apn1Δ apn2Δ ntg1Δ ntg2Δ mutant), results in
1075× increase in spontaneous mutation rates14, which likely
accounts for the extreme MMS sensitivity observed in this mutant
background.
Although we ﬁnd that the Shu complex exhibits improved
binding afﬁnity for double-ﬂap structures, we previously showed
that the Csm2-Psy3 heterodimer also binds to 5′ and 3′ DNA
overhangs19. In this context, the Shu complex could bind to a 5′
overhang that forms when a replicative polymerase stalls at a
DNA lesion and then dissociates from it. It is also possible that
other DNA repair factors or the replication machinery itself may
also contribute to Shu complex recruitment to DNA damage at a
replication fork. In this scenario, the Shu complex could recruit
Rad51 to stalled replication forks to facilitate a template switch.
Our work has important clinical implications as the inter-
dependency between DNA repair pathways needed during
replication is being exploited for cancer treatment. For example,
human BRCA1 and BRCA2 function during HR by promoting
resection and RAD51 activity, respectively36. BRCA1 and BRCA2
disruption is associated with hereditary breast and ovarian can-
cers. PARP inhibitors are effective in the treatment of patients
with BRCA1- and BRCA2-deﬁcient tumors37–39. Recent studies
have extended these observations and PARP inhibitors are now
being used to treat patients with RAD51 paralog-deﬁcient tumors
in clinical trials40. Therefore, upon replication stress when early
DNA repair steps are blocked by PARP inhibition, HR is required
to bypass the lesion. A recent study has implicated PARP1 in
ligation of Okazaki fragments where PARP inhibition prevents
Okazaki fragment ligation, which would then require HR for
removal41. In this replicative context, combined PARP inhibition
with HR deﬁciency (due to BRCA or RAD51 paralog mutation)
results in tumor cell lethality. Understanding the underlining
mechanisms of how BER intermediates, such as ssDNA breaks
and abasic sites, are recognized and channeled for repair through
HR is critical for exploiting DNA repair interdependency in
cancer therapy to ensure the most durable clinical response.
Methods
Strains and plasmids. The strains and plasmids used are listed in Supplementary
Table 3. All strains are isogenic with W303 RAD5+W1588-4C42 and W5059-1B43
with the exception of the APOBEC3B-mediated mutagenesis assay. In the
APOBEC3B-mediated mutagenesis, the yeast strains used for determining CAN1
mutation rates and spectra are derived from wild-type ySR12826, in which the
CAN1 gene is integrated approximately 16 kb to the left of ARS216. Construction
of ySR128-derived ung1Δ, mph1Δ, and ubc13Δ strains was described26,28. HygMX
cassettes for creating deletions of CSM2 and PSY3 were generated by PCR using
primers described in Supplementary Table 4 and plasmid template pAG32 (ref. 44).
After transformation and selection, gene deletions were conﬁrmed by PCR using
primers that ﬂank each gene (Supplementary Table 4). APOBEC3B expressing and
empty plasmids were created in the vectors pySR-419 and pSR-440 (ref. 26). A
fragment containing the LEU2 gene from pUG73 (ref. 45) was PCR ampliﬁed using
oligos oTM-74 and oTM-75. This fragment was then ligated into backbones cre-
ated from PCR ampliﬁcation of pySR-419 and pSR-440 with primers oTM-80 and
oTM-81. The resulting plasmids, pTM-19 (empty vector) and pTM-21 (APO-
BEC3B expression vector), were validated by Sanger sequencing. The primers used
for cloning and sequencing are found in Supplementary Table 4.
Cananvanine mutagenesis assay. Five individual CAN1 colonies of WT, csm2Δ,
psy3Δ, csm2-KRRR, psy3-KRK, and csm2-KRRR psy3-KRK were grown 2 mL YPD
or YPD medium containing 0.00033% MMS (18 h) overnight at 30 °C. The cultures
were diluted 1:10, with 250 µL plated on SC-ARG+ CAN or diluted 1:60,000, with
120 µL plated on SC. The plates were then incubated for 48 h at 30 °C. Colonies
were used to measure total cell number (SC) or forward mutation rates (SC-ARG
+ CAN). For each condition, colony count from at least four independent trails
was used to calculate a mutation rate using a web-based calculator (http://www.
mitochondria.org/protocols/FALCOR.htmL)46 and the Lea-Coulson method of the
median.
APOBEC3B-mediated mutation rate and mutation spectra. Yeast strains were
transformed with either pTM-19 (empty vector) or pTM-21 (APOBEC3B
expression plasmid) and selected on synthetic complete medium lacking leucine
(SC-leu). Individual isolates were plated on SC-leu at a density of approximately 50
cells per plate and grown to colony sizes of 7 × 107 cells (for empty vector) or 7 ×
106 cells (for APOBEC3B expression plasmid). Eight independent colonies were
then resuspended in water and plated on SC or SC-arginine medium supplemented
with 0.006% canavanine (SC+ can) and incubated for 3 days at 30 °C. Colonies
were used to measure total cell number (SC) or forward mutation rate (SC-ARG+
CAN). For each condition, data from at least three independent transformants
were used to calculate a mutation rate using a web-based calculator (http://www.
mitochondria.org/protocols/FALCOR.htmL)46 and the Lea-Coulson method of the
median. Mutation spectra were determined for APOBEC3B-expressing strains
plated on SC-leu medium at a density of about 50 cells per plate and grown until
colonies reached approximately 7 × 106 cells. The resulting colonies were replica-
plated to SC+ can medium and grown for 4 days. To isolate independent clonal
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Fig. 6 Model of Shu-mediated DNA strand-speciﬁc damage tolerance. The
Shu complex DNA-binding components, the Rad51 paralogs Csm2-Psy3,
bind to abasic sites at a double-ﬂap junction to promote Rad51-mediated
template switching while preventing AP endonuclease cleavage. MMS-
induced DNA damage is primarily repaired by the BER pathway. However, if
a replication fork encounters DNA damage such as an abasic site (yellow
star), then the fork can stall or collapse. The Shu complex (blue ovals) binds
abasic sites on the lagging strand template proximal to the dsDNA fork
stem. Shu complex DNA binding (1) promotes Rad51 ﬁlament formation
(green ovals) and (2) likely prevents AP endonuclease cleavage (orange
Pac-man) and DSB formation. Thus, the Shu complex mediates a DNA
strand-speciﬁc damage tolerance pathway enabling error-free lesion bypass
through a template switch using the newly synthesized sister chromatid.
This strand-speciﬁc lesion bypass pathway allows replication to continue
efﬁciently in an error-free manner and the abasic site to be repaired by BER
after the fork progresses
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colonies on SC+ can medium and after 3 days one colony from each was patched
onto YPDA medium. Genomic DNA was isolated from each patch and used as a
template for ampliﬁcation of the CAN1 gene by PCR using primers oTM-92 and
oTM-93 (Supplementary Table 4). The resulting PCR products were Sanger
sequenced (GenScript, Piscataway, NJ), using primers oTM-94, oTM-95, and
seqDG-91 (Supplementary Table 4) and the mutations inactivating CAN1 were
identiﬁed using the Geneious software package (Biomatters).
Growth assays. Yeast strains were incubated in 5 mL YPD medium overnight at
30 °C and then diluted to 5 mL OD600 0.2. The cultures were incubated for another
3 h at 30 °C to reach log phase, and 5 µL of culture at OD600 0.2 were ﬁvefold
serially diluted onto YPD medium or YPD medium containing 0.02% MMS. The
plates were incubated at 30 °C for 2 days and photographed. Cell viability assays
were performed by growing the indicated strains in 3 mL of YPD at 30 °C over-
night, and then diluting the culture to 0.2 OD600 for 3–4 h. The cultures were
all diluted to 0.5 OD600 in 1 mL YPD and diluted either 1:10,000 or 1:20,000 and
250 µL was plated onto YPD medium or YPD medium containing 0.012%, 0.02%,
0.03% MMS. The plates were incubated at 30 °C for 2 days before being counted.
Representative images were taken after 2 days of growth at 30 ˚C°C for one of the
experiments and the brightness and contrast was adjusted using Photoshop (Adobe
Systems Incorporated). The experiment was performed ﬁve times with standard
deviations calculated.
Western blot analysis. Five milliliters YPD was inoculated with the indicated cells
and grown overnight at 30 °C. The cells were diluted to OD600 0.2 in 5 mL YPD and
grown for 3 h at 30 °C. Whole-cell lysates of equal cell numbers (0.5 OD600) were
prepared by TCA precipitation47 and 10 of 50 µL protein preparation was run on a
10% SDS-PAGE gel where HA antibodies (sc-805; 1:500) were used to detect the
6HA tagged Csm2 and Psy3 proteins and Kar2 antibodies (Santa Cruz sc-33630;
1:200) were used as a loading control. The ﬁlms were scanned and adjusted for
contrast and brightness using Photoshop (Adobe Systems Incorporated). Unpro-
cessed and uncropped ﬁlm images are in source data ﬁle.
Yeast-two-hybrids. The yeast two-hybrid plasmid pGAD was used to express a
fusion of GAL4-activation domain and pGBD was used to express a fusion of the
GAL4 DNA-binding domain. The pGAD and pGBD indicated plasmids were
transformed into PJ69-4A2, and positive colonies were selected on synthetic
complete without tryptophane and leucine (SC-TRP-LEU) medium. Individual
colonies were grown to early log phase (OD600 0.2), and then 5 µL was spotted onto
medium to select for the plasmids (SC-LEU-TRP) or onto medium to select for
expression of the reporter HIS3 gene (SC-LEU-TRP-HIS), indicating a yeast two-
hybrid interaction. Plates were incubated for 2 days at 30 °C and subsequently
photographed. Each experiment was done in triplicate.
Protein expression and puriﬁcation. All Csm2-Psy3 heterodimers were cloned
into the dual expression plasmid pRSFDuet (EMD Millipore) which encode a
6XHIS-TEV tag on Csm2. Transformed E. coli [BL21-Codon+ (DE3, RIL) Agilent]
was grown at 37 °C to 0.6 OD600 and recombinant protein expression was induced
by addition of 0.2 mM isopropyl beta thiogalactoside (IPTG) at 18 °C overnight for
16–18 h. Cells were harvested by centrifugation. Approximately 10 g of cell pellet
was lysed in 60 mL of lysis buffer containing 20 mM Tris (pH 8.0), 500 mM NaCl,
10% glycerol, 5 mM imidazole, and 1 mM β-mercaptoethanol supplemented with
protease inhibitors (Roche) and DNAse (1 µg mL−1). Cells were lysed using an
emulsiﬂex and centrifuged at 30,000 × g for 1 h at 4 °C. Csm2 and Psy3 were co-
puriﬁed through nickel afﬁnity chromatography (Qiagen) using the N-terminal
His6-tag on Csm2 in Nickel binding buffer (20 mM Tris pH 8.0, 500 mM NaCl,
10 mM Imidazole, and 1 mM beta-mercaptoethanol). Csm2-Psy3 was washed on
the column with 50 mL of binding buffer containing 10, 15, and 20 mM imidazole
to remove contaminating proteins. The Csm2-Psy3 was eluted from the column
with elution buffer containing 20 mM Tris pH= 8.0, 500 mM NaCl, and 250 mM
Imidazole. Wild-type Csm2-Psy3 dimers used in the abasic binding experiments
were further puriﬁed using HiTrap Heparin HP (GE Healthcare) afﬁnity chro-
matography. The Csm2-Psy3 protein was loaded onto the heparin column equi-
librated in buffer containing Tris pH 8.0, 1 mM beta-mercaptoethanol, and 8%
glycerol. The complex was eluted with a gradient elution from 25% to 100% (Tris
pH 8.0, 1 M NaCl, 1 mM beta-mercaptoethanol, and 8% glycerol) over 75 mL. The
Csm2-Psy3 protein typically eluted around 400–600 mM NaCl. Since mutant
Csm2-Psy3 dimers fail to bind the heparin column, wild-type Csm2-Psy3 and
mutant Csm2-Psy3 constructs were puriﬁed using a HiTrap Q (GE Healthcare)
anion exchange column for a direct comparison of DNA-binding afﬁnities. Note
that this change in puriﬁcation scheme results in different binding afﬁnities
compared to the protein preparations that used the heparin column. All Csm2-
Psy3 constructs were subsequently puriﬁed by size exclusion chromatography
using a Sephacryl S200 column (GE Healthcare) in buffer (Tris pH 8.0, 1 M NaCl,
1 mM beta-mercaptoethanol, and 8% glycerol), eluting as a single peak (Supple-
mentary Fig. 3d) and visualized as heterodimers by SDS-PAGE electrophoresis
(Supplementary Fig. 1). Csm2-Psy3 protein concentration was determined by
absorbance at A280 with an extinction coefﬁcient of 54,320 M−1 cm−1. For full
description of Shu1 and MBP-Shu2 puriﬁcation see ref. 48. Brieﬂy, Shu1 and MBP-
Shu2 were expressed in E. coli (Rosetta [DE3]) by transforming cells with the pET-
DUET vector encoding 6XHIS-Shu1 and MBP-tagged Shu2 (tags located on the N-
terminus). Cells were grown in 2× LB broth containing 0.1 mM ZnCl2 at 37 °C
until OD600 0.8 was reached, recombinant protein expression was induced with a
ﬁnal concentration of 0.2 mM IPTG, and shifted to grow at 16 °C for 16 h. Cells
were harvested by centrifugation and 40 g of pellet was resuspended in 200 mL of
buffer with 300 mM KCL containing protease inhibitors. Cells were lysed by
sonication and centrifuged at 100,000g for 1 h at 4 °C. Then supernatant was
incubated with Ni-NTA resin, washed with buffer containing 150 mM KCl and
10 mM imidazole, and eluted by 200 mM Imidazole. Eluate was incubated for 2 h
with amylose resin with gentle mixing and eluted. Elution was run on a SuperDex
200 column in buffer with 150 mM KCl buffer. Protein eluted as a monodispersed
dimeric protein complex. Peak fractions were pooled, concentrated in an Amicon
Ultra micro-concentrator, snap frozen in liquid nitrogen, and stored at −80 °C. For
description of full puriﬁcation method of Rad51 see ref. 49. Unprocessed gel images
are in source data ﬁle.
Equilibrium-binding assays using FPA. Anisotropy experiments were performed
using a FluoroMax-3 spectroﬂuorometer (HORIBA Scientiﬁc) and a Cary Eclipse
Spectrophotometer. For unmodiﬁed forks, ﬂuorescein dT was incorporated at the
5′ single-stranded end of the fork (Fig. 1b). For double-ﬂap substrates containing
abasic site analogs, the label was placed on the single-stranded end of the oligo-
nucleotide that did not contain the abasic site analog. Anisotropy measurements
were recorded in a 500 µL cuvette containing 20 mM Tris pH 8.0 and 20 nM of
ﬂuorescein-labeled double-ﬂap substrate as a premixed sample of puriﬁed Csm2-
Psy3 protein and substrate (20 nM AP6+ 1.6 μM Csm2-Psy3 dimer in 1M NaCl)
was titrated into the cuvette. Fluorescence anisotropy measurements were recorded
using the integrated polarizer and excitation and emission wavelengths of 466 and
512 nm, respectively, with path lengths of 10 nm. Titrations were carried out until
anisotropy became unchanged. At the end of each titration, the DNA substrate was
competed off with 1M NaCl to conﬁrm that the increase in anisotropy was
explained by bona ﬁde electrostatic interactions with Csm2-Psy3. All experiments
were performed in triplicate with multiple preparations of the recombinant pro-
teins. Dissociation constants (Kd) were calculated by ﬁtting our data to a one-site
binding model using the equation for a rectangular hyperbola [Y= Bmax*X/(Kd+
X)], with PRISM7 software (Supplementary Tables 1 and 2). Anisotropy experi-
ments with 2.5 and 5 nM substrate concentrations were ﬁt to a quadratic equation
[Y=M* ((x+D+ Kd) −sqrt(((x+D+ Kd)2)–(4*D*x)))/(2*D)], with
PRISM7 software. Unprocessed raw anisotropy values are in the source data ﬁle.
Electrophoretic mobility shift assay. EMSA reactions were performed in buffer
containing 25 mM Tris-HCl (pH 8.0), 50 mM NaCl, 1 mM DTT, 100 μg mL−1
bovine serum albumin (BSA) (Sigma), and 5% glycerol. Brieﬂy, FITC-annealed
substrates (25 nM) or Cy3-annealed substrates (5 nM) were incubated with
increasing concentrations of Csm2-Psy3, Shu1-Shu2, or Csm2-Psy3-Shu1-Shu2
(0, 50, 100, 200, 400, 600, and 800 nM) at 25 °C for 5 min. At the end of the
reaction, 0.4 µL of an NP40 and dI/dC were added to a ﬁnal concentration of 0.23%
and 7.7 ng mL−1, respectively. Samples were run on a 5% TBE (pH 8.5) acrylamide
gel containing 5% glycerol at 4 °C for 1 h at 70 V. Gels were imaged on a Typhoon
9400 Variable Mode Imager (GE Healthcare) with an excitation wavelength of
488 nm and emission wavelength of 526 nm with a PMTV at 650. Free or bound
substrate intensities were quantiﬁed using ImageQuant TL 1D v8.1 software.
Quantiﬁcation of Csm2-Psy3 bound to the different ﬂap substrates was performed
by dividing the % bound complex by the total substrate intensity in each lane. Error
bars represent standard deviations. Unprocessed and uncropped typhoon images
are in source data ﬁle.
Chromatin fractionation. Chromatin fractionation was based on refs. 50,51 with
modiﬁcation. Five milliliters YPD was inoculated with the indicated cells and
grown overnight at 30°C. The cells were diluted to 0.2 OD600 in 50 mL YPD and
grown for 3 h at 30C. The cells were then diluted to 0.3 OD600 in 50 mL fresh YDP
with 20 μM α-factor (GeneScript). After 2 h incubation at 30 °C, the cells were
pelleted and washed with 50 mL YPD. The culture was diluted to 0.5 OD600 in
50 mL fresh YPD or YPD containing the indicated MMS concentration (0.01%,
0.02%, or 0.03%) or HU concentration (50 or 200 mM). After 1 h incubation at
30°C, 30 OD600 cells were washed with 50 mL ice-cold water and resuspended in
2 mL pre-spheroplast buffer (100 mM PIPES/KOH pH 9.4, 10 mM DDT, 0.1%
NaN3)50 for 10 min at room temperature. The cells were pelleted and then
resuspended in 3 mL spheroplast buffer (50 mM K2HPO4/KH2PO4 pH 7.5, 0.6 M
Sorbitol, 10 mM DTT, 0.1 μg mL−1 Zymolyase 100T [amsbio])50 and incubated for
40 min at 30°C (120 rpm). The spheroplasts were pelleted and washed with ice-cold
wash buffer (50 mM HEPES/KOH pH 7.5, 100 mM KCl, 2.5 mM MgCl2, 0.4 M
sorbitol)50. The spheroplasts were pelleted and resuspended in 80 μL of extraction
buffer (wash buffer with 1 % Triton X-100, 1 mM DTT, protease inhibitors, and
2 mM PMSF)51. The spheroplasts were lysed by vortexing for 5 min with inter-
mittent incubation on ice. Eighty microliters of HU loading buffer (8M urea, 5%
SDS, 200 mM Tris pH 6.8, 1 mM EDTA, 0.02% w/v bromophenol blue, 0.2 M
DTT)47 was added to 20 μL of each lysate and set aside for analysis [whole-cell
lysate (W)]. The remaining lysate was loaded on top of a 50 μL sucrose cushion
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(wash buffer with 30% sucrose, 0.25% triton X-100, 1 mM DTT, protease inhibi-
tors, and 2 mM PMSF)51 and centrifuged 10 min at 4 °C at 20,000 × g. Eighty
microliters of HU loading buffer was added to 20 μL from the top layer and set
aside for analysis [non-chromatin fraction (S)]. The chromatin fraction (C) pellets
were resuspended in 100 μL of HU loading buffer. Five microliters of the W, S, and
C samples were run on a 12% SDS-PAGE gel and western blot analysis was
performed. HA antibodies (sc-805; 1:500) were used to detect the 6HA-tagged
Csm2 protein, Kar2 antibodies (Santa Cruz sc-33630; 1:200), GAPDH (UBPbio
Y1040; 1:10000), Rfa1 (Abcam ab221198; 1:6000), and H2B antibodies (Active
Motif #39237, 1:1000) were used for controls. The ﬁlms were scanned and adjusted
for contrast and brightness using Photoshop (Adobe Systems Incorporated).
Unprocessed and uncropped ﬁlm images are in source data ﬁle.
Chromatin fractionation data analysis. Each experimental condition was repe-
ated 3–5 times. The densitometry analysis was performed using ImageJ software52
to quantify the whole-cell lysate (W), non-chromatin fraction (S), and chromatin
fraction (C). To analyze the amount of Csm2 that is chromatin associated, the
signal of Csm2 in the C fraction was divided by the W fraction. Kar2 chromatin
association was also calculated by dividing Kar2 C fraction by the W fraction. To
account for chromatin extraction efﬁciency, the calculated Csm2 chromatin asso-
ciation value was then divided by the corresponding Kar2 chromatin association
value. Finally, to account for loading differences, we compared the Csm2 and Kar2
W fractions. To compare Csm2 chromatin enrichment between experiments and
obtain fold changes, we set the untreated Csm2–6xHA strain chromatin signal to 1
and the averages of each trial were plotted with standard deviations and sig-
niﬁcance determined by unpaired two-tailed Student’s t-test. Unprocessed and
uncropped ﬁlm images are in source data ﬁle.
Synthesis of oligonucleotides containing an abasic residue. Standard DNA
phosphoramidites with labile phenoxyacetyl (PAC), acetyl (Ac), or isopropyl-
phenoxyacetyl (iPrPAC) protecting groups, dSpacer phosphoramidite, deox-
ythymidine CPG, deoxycytidine CPG, and standard solid phase synthesis reagents
were purchased from Glen Research (Sterling, VA). Solid phase synthesis was
performed on a Mermade-4 (Bioautomation, Plano, TX, USA) automated syn-
thesizer. DNA synthesis and deprotection were performed using standard protocols
following the manufacturer’s recommendations. After deprotection, DNA was
analyzed for purity using reverse phase HPLC. The HPLC system consisted of a
Waters 1525 pump system and a Waters 2998 photodiode array detector using a
Waters XBridge column (C18 130 Å) in 0.1 M triethylamine acetate and 80:20
acetonitrile:water in 0.1 M triethylamine acetate at 25 °C. Strands showing sig-
niﬁcant impurity proﬁles were puriﬁed by either HPLC or gel if necessary. The
DNA band was excised and eluted overnight in TE0.1 buffer (10 mM Tris, 0.1 mM
EDTA, pH 7.5). Eluted DNA was desalted using a C18 Sep-Pack cartridge (Waters,
Milford, MA, USA). All DNA was characterized by MALDI-TOF mass spectro-
metry using a 3-hydroxypicolinic acid matrix. The sequence of the abasic site
analog containing DNA is shown in Supplementary Table 5. The sequences of the
Cy3 labeled double-ﬂap, 5′ ﬂap, 3′ ﬂap, and static replication fork are shown in
Supplementary Table 6 and were adapted from ref. 30.
Pull-down assays. Pull-down assays were performed by incubating 25 μL Ni beads
(Qiagen) with 1 μM of APE1 and 1 μM Csm2-Psy3 in 20 mM Tris (pH 8.0), 50 mM
NaCl, 5 mM MgOAc2, 5% glycerol, 1 mM DTT, 2 mM ATP, and 0.5 mgmL−1 BSA
to a ﬁnal volume of 30 μL. The reaction was incubated over night at 4°C with
rotation and then subsequently pelleted at 3000 × g for 5 min. Unbound sample
was saved for gel analysis and beads were washed twice with 500 μL of buffer and
bound proteins were eluted with 5 μL of binding buffer and 5 μL of SDS-PAGE
loading buffer (250 mM Tris-Cl pH 6.8, 8% SDS, 0.2% bromophenol blue, 40%
glycerol, and 20% beta-mercaptoethanol) followed by boiling for 4 min. Proteins
were separated on a 15% SDS-PAGE gel for analysis. Gel image was adjusted for
contrast. Unprocessed gel images are in source data ﬁle.
APE1 endonuclease activity assay. All endonuclease experiments were performed
in vitro using recombinant components. One hundred nanomolar of 3′ ﬂuorescein-
labeled double-ﬂap substrate was dissolved in reaction buffer containing 20mM
HEPES (pH 7.5), 50 mM NaCl, 1 mM MgCl2, 5% glycerol, 1 mM DTT, and
0.5mgmL−1 BSA. DNA substrate and Csm2-Psy3 were incubated for 5 min before
adding human APE1 (ref. 53) (generously provided as a gift from Sam Wilson,
NIEHS and New England BioLabs) or buffer. For the titration experiments, the
reaction mix contained AP6 and either buffer alone or dilutions of Csm2-Psy3
ranging from 50 nM to 5 µM. One hundred nanomolar APE1 was then added and
the reaction mixes were incubated at room temperature for 1 min and stopped by
adding an equal volume of formamide loading buffer (95% formamide, 5 mM
EDTA) and boiling for 5 min. Samples were then resolved by running on 8% TBE-
urea gels at 35mA for 8 min. Gels were analyzed using the image processing
software ImageJ52. Relative enzyme activity was determined by measuring the ratio
of uncut to cut APE1 products in each lane. Results for each condition were
averaged across experimental triplicates and then normalized against a control
APE1 condition without added Csm2-Psy3. The time course assay was performed
similarly with the following modiﬁcations: samples contained ﬁxed amounts of
APE1 (100 nM) and Csm2-Psy3 (5 µM). Reactions were then incubated at room
temperature for 30min, with samples collected at intervening time points. Reactions
conta1ining Rad51 were performed as described for Csm2-Psy3 with the following
modiﬁcations: Reaction buffer for all Rad51-involved assays contained 20mM Tris
(pH 8.0), 50 mM NaCl, 5 mM MgOAc2, 5% glycerol, 1 mM DTT, 2mM ATP, and
0.5 mg mL−1 BSA. Samples were incubated as described for Csm2-Psy3 before
adding human APE1 or buffer. Titrations contained dilutions of Rad51 ranging
from 1 to 10 µM for the Rad51 inhibition assays. For assays measuring the com-
bined effect of Rad51 and Csm2-Psy3, titrations of Csm2-Psy3 ranging from 50 nM
to 5 µM were supplemented by the addition of 2 µM Rad51. Titrations involving the
entire Shu complex (Csm2-Psy3-Shu1-Shu2) were performed exactly as described
for Csm2-Psy3, with the concentrations of Shu1-Shu2 equimolar to Csm2-Psy3.
Quantiﬁcation, averaging, and normalization for all experiments were performed as
described for Csm2-Psy3. Gels were contrast adjusted and unprocessed and
uncropped ﬁlm images are available in the source data ﬁle.
Data availability
The authors declare that the source data (Fig. 1b, d, Fig. 2c, d, Fig. 3b–d, Fig. 4b–d,
Fig. 5a–d, Supplemental Fig. 1, Supplemental Fig. 2a, b, Supplemental Fig. 3a–c Fig. 4a, b,
Fig. 5a, b, Fig. 6a, b, Fig. 7a, Fig. 8a–c, and Fig. 9) support the ﬁndings in this study and
are available within the paper, within the supplementary ﬁles, and all data are provided as
a Source Data ﬁle. All data are also available from the authors upon reasonable request.
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